The Deal Register
Database › Debt financing › Quebec Expands Public Funding for CAPVAXIVE®

Debt financing

Quebec Expands Public Funding for CAPVAXIVE®

Lane
Debt financing
Announced
05 Nov 2025
Province
Quebec
Industry
Unclassified
Status
Announced
What the filing says
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the province of Quebec has added CAPVAXIVE ® , a 21-valent pneumococcal conjugate vaccine, to their publicly funded adult immunization program.
Source

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe